Europe Markets: European stocks and Dow futures rise as U.S. and China report positive trade talks

This post was originally published on this site

In this July 31, 2019, file photo U.S. Trade Representative Robert Lighthizer, center, gestures as he chats with Chinese Vice Premier Liu He, at right with Treasury Secretary Steven Mnuchin, left, looking on after posing for a family photo at the Xijiao Conference Center in Shanghai. U.S. and Chinese trade envoys discussed strengthening coordination of their government’s economic policies during a phone meeting Tuesday, Aug. 25, 2020, the Ministry of Commerce announced.

Ng Han Guan/Associated Press

European stocks climbed Tuesday, getting a boost from the U.S. and China holding trade talks.

Up 1.6% on Monday, the Stoxx Europe 600 SXXP, +0.63% rose 0.5%. Airlines rose, with International Airlines Group IAG, +5.27% and easyJet EZJ, +4.79% gaining ground.

The German DAX DAX, +0.80%, which crossed the 13,000 level on Monday, rose 0.8%. The U.K. FTSE 100 UKX, +0.59% and French CAC 40 PX1, +1.02% also rose.

After a 378-point gain for the Dow Jones Industrial Average DJIA, +1.35% on Monday on news the U.S. gave tentative approval to blood plasma as a COVID-19 treatment, futures on the Dow YM00, +0.81% rose 178 points.

China reported that there was a “constructive” trade discussion that included Vice Premier Liu He, U.S. Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin. The U.S. said both sides “see progress and are committed to taking the steps necessary to ensure the success of the agreement.” Previously scheduled talks between the sides had been delayed.

That tone contrasts with the election campaigning of U.S. President Donald Trump, who said on Sunday in an interview he would be open to completely decoupling from China.

Of stocks in the spotlight, Aveva AVV, +1.59% rose 2% after it said it’s buying OSIsoft for $5 billion in a mostly cash deal to expand its position in industrial software.

Aveva is buying the company that’s 53% held by its founder and 45% held by SoftBank 9984, +2.44% and will fund the deal with a $3.5 billion sale of discounted shares, or rights issue. Aveva’s 60% shareholder Schneider Electric SU, +0.80% supports the deal and will fully take up its share of the rights issue.